ANZ FY Profit Climbs

By RTTNews Staff Writer ✉ | Published: 10/27/2021 11:06 PM ET

Australia And New Zealand Banking Group Ltd.(ANZ.AX,ANZBY.PK,ANZ) reported that its profit after tax for the year ended 30 September 2021 was A$6.16 billion, up 72% on the prior year with a key driver being the partial reversal of COVID-19 related credit provisions. On a per share basis, net income was 204.9 cents up from 118.0 cents in the previous year.

Cash profit from continuing operations, before credit impairment and tax, was A$8.396 billion, flat to the prior year.

Net interest income for the quarter grew to A$14.16 billion from A$14.05 billion last year.

The company said its board determined a final dividend of 72 cents per share was appropriate, taking the total dividend for 2021 to 142 cents per share, up by 82 cents per shareon the prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Editors Pick

United Airlines, Archer To Launch First Air Taxi Route In Chicago

United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route.

Aunt Millie's Our Family White Hot Dog Buns Recalled

Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie.

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.